DDX41 and infection: Taken together, the immunologic and genetic data suggest that vaccine-induced anti-V3 Abs exerted immune pressure on viruses bearing I307, decreasing the number of infections by viruses carrying the same I307 residue that RV144 V3 Abs can target (Fig. 2A).